{
  "docId": "019de515-e815-738a-9db4-c54117f0c213",
  "docSlug": "5b4399e5f29e85eea5be20288be8cb74",
  "documentTitle": "Bluejay | Investor Presentation Deck | 18 slides",
  "authorId": "bluejay",
  "authorName": "Bluejay Diagnostics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 18,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "key_messages",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 2,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de515-e815-738a-9db4-c54117f0c213/3",
  "deckHref": "/decks/019de515-e815-738a-9db4-c54117f0c213",
  "deckJsonHref": "/decks/019de515-e815-738a-9db4-c54117f0c213.json",
  "deckAnchorHref": "/decks/019de515-e815-738a-9db4-c54117f0c213#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.06,
        "w": 0.833,
        "x": 0.084,
        "y": 0.529
      },
      "kind": "list",
      "text": "Market Opportunity: Symphony™ Product Pipeline addresses multi-billion-dollar market, Near-patient testing (NPT) for monitoring of disease progression",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "48ffc23a-9a3d-441e-8a21-df6bbc0db21e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.833,
        "x": 0.084,
        "y": 0.389
      },
      "kind": "list",
      "text": "Symphony™ Product Lead Candidate: IL-6 Assay: Completed initial clinical studies for measuring IL-6 in critical care settings, Conducting additional studies to support planned FDA submission",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6a0a155c-e603-46fe-a8cf-6e7fa0ccf780",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.029,
        "w": 0.833,
        "x": 0.084,
        "y": 0.809
      },
      "kind": "list",
      "text": "Capital Efficient Model: $6.8 M in cash as of March 31, 2023",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "88469ee3-bab0-4da0-bd41-b392190b089b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.833,
        "x": 0.084,
        "y": 0.249
      },
      "kind": "list",
      "text": "Novel Proprietary Platform: Uses whole blood (no pre-processing), Results in ~20 minutes",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ce9245b7-655c-44f0-9210-847f3e5445b2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.833,
        "x": 0.084,
        "y": 0.669
      },
      "kind": "list",
      "text": "Commercial Strategy: Sales model initially targets clinical sites and commercial partnerships, Large, well-respected clinical sites are built-in commercial customers",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f2d72256-9081-4314-88e9-6baed3ba4d63",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.35,
        "x": 0.134,
        "y": 0.953
      },
      "kind": "source-note",
      "text": "The Symphony™ System and Symphony™ Cartridge have not been cleared or approved by the U.S. FDA",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3f81f9c0-ebb4-42b8-8a5f-d409263c53d6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.346,
        "x": 0.618,
        "y": 0.953
      },
      "kind": "source-note",
      "text": "Copyright ©2023 Bluejay Diagnostics, Inc. All rights reserved in all slides | June 2023 3",
      "attrs": {
        "numbered": true
      },
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b28094a1-6741-4f1c-9581-adf7e83bff7a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.036,
        "w": 0.899,
        "x": 0.036,
        "y": 0.09
      },
      "kind": "title",
      "text": "Bluejay Diagnostics: Optimizing Turnaround Times to Improve Patient Outcomes",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ee7caaec-af24-4ba8-8117-6aa71e11f029",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "647dfec6-fb12-46a8-8e97-c5ec664dc747",
      "evidence": "list/bullet: Market Opportunity: Symphony™ Product Pipeline addresses multi-billion-dollar market",
      "confidence": 0.7
    },
    {
      "name": "Problem Statement Canvas",
      "slug": "problem-statement-canvas",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "f926581a-14df-4d13-aecf-b0bb438806f6",
      "evidence": "list/bullet: Market Opportunity: Symphony™ Product Pipeline addresses multi-billion-dollar market",
      "confidence": 0.6
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 5,
      "from": 3,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "155a99ef-cd6f-469b-92cd-328ac487de6a",
      "evidence": "The deck presents the Symphony IL-6 Test as a solution, highlighting its potential clinical advantages and market opportunity",
      "position": 1,
      "objective": "Why is Bluejay Diagnostics' Symphony IL-6 Test important for improving patient outcomes?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.6,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}